Skip to main content

Genomics to Play Role In New Memorial Sloan-Kettering Grad School

NEW YORK, Nov. 18 (GenomeWeb News) - When it opens its doors in July 2006, the Louis V. Gerstner, Jr. School of Biomedical Sciences at the Memorial Sloan-Kettering Cancer Center will try to bring together basic cancer research, including genomics and various cell-signaling disciplines, with clinical practice, said Thomas Kelly, director of the Sloan-Kettering Institute and provost of the new graduate school in a statement today.


The school hopes to offer a curriculum including a one-year course covering "all aspects" of cancer biology, according to the statement.


Named after Louis Gerstner, a board of overseers vice president, philanthropic donor, and president of the board of trustees, the school will be housed in a new research building with "open floor labs" dedicated to chemical biology, immunology, human oncology and pathogenesis, and molecular pharmacology.


When the school opens, it will enroll 10-12 students leading to a PhD in cancer biology, said the statement, eventually leading to a total enrollment of 60.

The Scan

Gap in COVAX Doses

BBC News reports that COVAX is experiencing a vaccine shortfall, as the Serum Institute of India has paused exports.

Sanofi, GSK Report Promising Results

The Wall Street Journal reports that the candidate SARS-CoV-2 vaccine from Sanofi and GlaxoSmithKline has had encouraging early results.

Influence of Luck

The New York Times examines how the US avoided variant-fueled increases in COVID-19 cases.

PLOS Papers on Retina GWAS, Hantaan Virus, COVID-19 Phenome-Wide Association Study

In PLOS this week: genome-wide association study of retinal morphology, analysis of hantaan virus found in a mouse, and more.